# Mechanistically-Specific Hypotheses: BACE1 Normal Physiological Functions and Adverse Effect Risks
These hypotheses address the critical gap that BACE1 inhibitor development must account for essential physiological roles beyond amyloid precursor processing.
---
## Hypothesis 1: BACE1-Dependent NRG1 Type III Cleavage Controls Node of Ranvier Stability and Saltatory Conduction
**Mechanism:**
BACE1 constitutively cleaves neuregulin-1 (NRG1) type III at the axonal membrane, releasing the EGF domain that activates ErbB2/3 receptors on adjacent Schwann cells. This signaling is essential for the formation and maintenance of the Node of Ranvier structure, where voltage-gated sodium channels (Nav1.6, encoded by *SCN8A*) cluster at high density. BACE1 inhibition would disrupt NRG1/ErbB signaling, leading to paranodal junction instability and altered sodium channel clustering, impairing rapid action potential propagation along myelinated axons.
**Key Evidence:**
- BACE1-null mice exhibit hypomyelination with a Trembler-like phenotype and reduced NRG1 cleavage products (PMID: 11891194, 12037568)
- NRG1 type III haploinsufficiency phenocopies BACE1 null peripheral myelination defects (PMID: 12376594)
**Testable Prediction:**
Conditional BACE1 deletion specifically in neurons (Synapsin-Cre; BACE1-flox) will cause disorganization of paranodal markers (caspr, neurofascin-155) and decreased Nav1.6 clustering at nodes, without affecting central myelination—demonstrating axonal-autonomous BACE1 requirements for nodal architecture. Electron microscopy will reveal disrupted paranodal loops.
**Target Gene/Protein:** NRG1 Type III / BACE1
---
## Hypothesis 2: BACE1 Regulates GABAergic Interneuron Survival via Caspase-3 Suppression Through Multiple Substrate Processing
**Mechanism:**
BACE1 constitutive activity maintains an anti-apoptotic environment in developing parvalbumin-positive (PV+) interneurons by processing substrates that suppress caspase-3 activation. Specifically, BACE1 cleaves the death domain-associated protein Daxx and may process neuregulin-1, which signals through ErbB4 on PV+ interneurons to activate PI3K/Akt survival pathways. Chronic BACE1 inhibition would lead to accumulation of pro-apoptotic substrates and reduced Akt phosphorylation, selectively increasing apoptosis in PV+ interneurons during the critical postnatal window (P14-P30), reducing perisomatic inhibition and contributing to seizure risk.
**Key Evidence:**
- ErbB4 is highly expressed on GABAergic interneurons and promotes their survival (PMID: 15105422)
- BACE1 inhibitors cause seizure activity in animal models and human trials (PMID: 21549844)
**Testable Prediction:**
Chronic BACE1 inhibitor treatment (7 days) in mice during P14-P30 will cause a >30% reduction in PV+ interneuron density in hippocampal CA1 stratum pyramidale, measured by stereological counting, and increased cleaved caspase-3 immunoreactivity specifically in PV+ cells. This effect will be reversed by co-administration of a caspase-3 inhibitor (z-DEVD-fmk).
**Target Gene/Protein:** Daxx / ErbB4 / PV+ interneurons
---
## Hypothesis 3: BACE1 Supports Axonal Integrity Through Cleavage of Axon Guidance Molecules That Regulate Retrograde Neurotrophic Signaling
**Mechanism:**
BACE1 processes multiple axon guidance substrates including NCAM-180, L1CAM, and neurofascin, generating fragments that regulate cytoskeletal dynamics and retrograde signaling. Specifically, BACE1 cleavage of neurofascin generates a C-terminal fragment that translocates to the nucleus and regulates gene expression. Additionally, BACE1-mediated shedding of L1CAM ectodomain is required for proper interaction with src-family kinases at the growth cone. BACE1 inhibition would disrupt retrograde neurotrophic signaling (TrkA/B-mediated MAPK and PI3K pathways), leading to axonal degeneration particularly in peripheral sensory neurons with long axons.
**Key Evidence:**
- BACE1 cleaves